Showing results (101-110 of 160) with videos related to
Sort By:
Pageof 16
Journal of Hematology & Oncology|July 6, 2017
Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysisYing-Jun Chang, Yu Wang, Yan-Rong Liu, et al.Journal of Hematology & Oncology|April 2, 2020
Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized studyYing-Jun Chang, Yu Wang, Lan-Ping Xu, et al.Blood|June 12, 2014
Who is the best donor for a related HLA haplotype-mismatched transplant?Yu Wang, Ying-Jun Chang, Lan-Ping Xu, et al.Cellular & Molecular Immunology|January 7, 2021
Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantationHuidong Guo, Ying-Jun Chang, Yan Hong, et al.Frontiers in Oncology|August 8, 2022
Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab TreatmentDao-Xing Deng, Shuang Fan, Xiao-Hui Zhang, et al.Bone Marrow Transplantation|May 10, 2020
Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibodyYing-Jun Chang, Lan-Ping Xu, Yu Wang, et al.Leukemia & Lymphoma|February 10, 2016
Combined model of the EBMT score modified model and the HCT-CI improves the stratification of high-risk patients undergoing unmanipulated haploidentical blood and marrow transplantationYing-Jun Chang, Hong-Tao Wang, Lan-Ping Xu, et al.Annals of Hematology|March 13, 2021
Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantationJing Liu, Xiao-Hui Zhang, Lan-Ping Xu, et al.Frontiers in Immunology|February 14, 2022
Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry StudiesMeng-Zhu Shen, Xiao-Hui Zhang, Lan-Ping Xu, et al.Therapeutic Advances in Hematology|January 31, 2022
Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantationMeng-Zhu Shen, Xin-Xin Liu, Zhi-Yuan Qiu, et al.Pageof 16